Biologically Active Small Molecules

A first generation, selective SGLT inhibitor that blocks glucose transport with about 100-fold selectivity for SGLT2 (Ki = 6 nM EC50 = 1.1 nM) over SGLT1 (Ki = 390 nM) 0.

A fluorescent probe which is commonly used to stain DNA and chromosomes for fluorescent microscopy and flow cytometry applications characterized by ultraviolet (max 358 nm) excitation and blue (max 461 nm) emission wavelengths.

A fluorescent probe which is commonly used to stain DNA and chromosomes for fluorescent microscopy and flow cytometry applications characterized by ultraviolet (max 358 nm) excitation and blue (max 461 nm) emission wavelengths.

A fluorescent probe which is commonly used to stain DNA and chromosomes for fluorescent microscopy and flow cytometry applications characterized by ultraviolet (max 358 nm) excitation and blue (max 461 nm) emission wavelengths.

Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are highly specific and potent allosteric inhibitors of HIV-1 reverse transcriptase. Dapivirine, a diarylpyrimidine derivative of the potent NNRTI efavirenz (Item No.

Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are highly specific and potent allosteric inhibitors of HIV-1 reverse transcriptase. Dapivirine, a diarylpyrimidine derivative of the potent NNRTI efavirenz (Item No.

Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are highly specific and potent allosteric inhibitors of HIV-1 reverse transcriptase. Dapivirine, a diarylpyrimidine derivative of the potent NNRTI efavirenz (Item No.

Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are highly specific and potent allosteric inhibitors of HIV-1 reverse transcriptase. Dapivirine, a diarylpyrimidine derivative of the potent NNRTI efavirenz (Item No.

An orally bioavailable inhibitor of HIF prolyl hydroxylase that increases HIF stability and action induces an effective EPO response and stimulates non-EPO mechanisms of erythropoiesis.

An orally bioavailable inhibitor of HIF prolyl hydroxylase that increases HIF stability and action induces an effective EPO response and stimulates non-EPO mechanisms of erythropoiesis.

An orally bioavailable inhibitor of HIF prolyl hydroxylase that increases HIF stability and action induces an effective EPO response and stimulates non-EPO mechanisms of erythropoiesis.

An orally bioavailable inhibitor of HIF prolyl hydroxylase that increases HIF stability and action induces an effective EPO response and stimulates non-EPO mechanisms of erythropoiesis.